IFP Advisors’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

IFP Advisors’s Portfolio NDRM Stock Details NDRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-600	Closed	-$23K	–	4296
2018 Q1	$23K	Hold	600	–	–	﹤0.01%	2313
2017 Q4	$23K	Sell	600 -1,050	-64%	-$40.8K	﹤0.01%	2345
2017 Q3	$64K	Sell	1,650 -1,850	-53%	-$68.1K	﹤0.01%	1845
2017 Q2	$105K	Buy	3,500 +400	+13%	+$10.4K	﹤0.01%	1505
2017 Q1	$82K	Buy	+3,100	New	+$76.8K	﹤0.01%	1638

IFP Advisors's NDRM Position: Q2 2018 in Review

IFP Advisors sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q2 2018, closing a stake of 600 shares — an estimated $23K sold.

IFP Advisors first reported a position in NDRM in Q1 2017 and held it in 5 quarters. The position peaked at $105K in Q2 2017. 0 funds tracked by Wall St. Rank hold NDRM as of Q2 2018.

IFP Advisors reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q2 2018 after selling out during the quarter.
IFP Advisors sold 600 NeuroDerm Ltd. Ordinary Shares shares in Q2 2018, an estimated $23K.
IFP Advisors first reported a position in NeuroDerm Ltd. Ordinary Shares in Q1 2017 and held it in 5 quarters.
IFP Advisors's NeuroDerm Ltd. Ordinary Shares position peaked at $105K in Q2 2017.
0 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q2 2018.

Based on IFP Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.